Increasing Diversity in Clinical Trials: What’s Working and What’s Not

Published: 05 Jun 2026

Increasing diversity in clinical trials requires more than updated enrollment targets. It demands infrastructure: community trust, advocacy partnerships, and trial designs that reflect real-world barriers to participation.

What is working

• Community-engaged trial design with advocacy co-leads
• Decentralized and culturally responsive outreach
• Cross-sector learning between pharma, sites, and patient organizations

What is not working

• Late-stage outreach without trusted community intermediaries
• One-size-fits-all recruitment that ignores rare disease fragmentation

Explore our platform · Join the network · Our health equity mission